How a new depression pill is absorbed in the body
This study tests whether a new version of an antidepressant pill is absorbed the same way as the existing one, and whether food changes how it is absorbed. Participants take the pill and have blood tests to measure drug levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- Your weight is at least 45 kg (if female) or 50 kg (if male), and your body mass index is between 19 and 28
- You are generally healthy, with no major medical conditions
- You agree to use barrier contraception (e.g., condoms) for 6 months after the trial and not donate sperm or eggs
- You can commit to the study schedule and follow the protocol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
This trial tests how a new drug called ABSK-011 is absorbed by the body when taken with a low-fat meal, a high-fat meal, or a stomach acid medicine. Healthy volunteers are needed to help understand these effects.
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.
This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.
This study tests an experimental oral pill called azetukalner against a placebo to see if it safely reduces symptoms of major depressive disorder. It is for adults who are currently in a depressive episode lasting 6 weeks to 2 years and have not already tried multiple antidepressants that failed.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.